2025-05-13 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided. The report is structured with numerical data first, followed by brief analysis, and is written in English.

**Report on Natera Inc. (NTRA)**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** NTRA
*   **Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing.

*   **Cumulative Return (NTRA):** 137.63%
*   **Cumulative Return (VOO):** 88.10%
*   **Absolute Deviation:** 49.5
*   **Relative Deviation:** 14.6 (Indicates current deviation is at the 14.6th percentile of historical deviation range).

**Analysis:** NTRA has significantly outperformed the S&P 500 (VOO) over the period examined. However, the relative deviation percentile suggests that the degree of outperformance is low compared to some historic periods.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B) |
|------------|---------|---------|----------|--------|--------|
| 2015-2017  | -6.0%   | 62.4%   | -34.0%   | -0.1   | 1.2    |
| 2016-2018  | 29.0%   | 80.1%   | 11.0%    | 0.0    | 1.9    |
| 2017-2019  | 159.0%  | 80.1%   | 128.0%   | 1.3    | 4.6    |
| 2018-2020  | 530.0%  | 80.1%   | 501.0%   | 0.7    | 13.6   |
| 2019-2021  | 355.0%  | 62.9%   | 298.0%   | 0.3    | 12.8   |
| 2020-2022  | -119.0% | 62.9%   | -127.0%  | 0.3    | 5.5    |
| 2021-2023  | -482.0% | 69.9%   | -501.0%  | 1.3    | 8.6    |
| 2022-2024  | -75.0%  | 70.6%   | -94.0%   | 1.3    | 21.6   |
| 2023-2025  | 86.0%   | 72.8%   | 55.0%    | 0.9    | 21.5   |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate shows significant volatility, with periods of high growth and substantial losses.
*   **MDD:** Maximum Drawdown figures indicate high levels of risk, with drawdowns exceeding 60% in most periods.
*   **Alpha:** The Alpha values are also highly variable, suggesting that NTRA's performance is not consistently linked to market movements.
*   **Beta:** Beta values are relatively low, suggesting that NTRA's stock price is not highly correlated with the S&P 500 index.
*   **Cap(B):** The capitalization increased in the last period.

**2. Recent Price Action**

*   **Current Price:** 157.29
*   **Previous Close:** 151.95
*   **Change:** 3.51
*   **5-Day Moving Average:** 157.48
*   **20-Day Moving Average:** 152.69
*   **60-Day Moving Average:** 150.32

**Analysis:** The current price is above both the 20-day and 60-day moving averages, suggesting an upward trend.  The recent price increase is significant, indicating positive momentum.

**3. Market Risk Indicators**

*   **Market Risk Indicator (MRI):** 0.3676 (Low Risk)
*   **RSI:** 63.04 (Approaching overbought territory)
*   **PPO:** 0.34
*   **Recent (20-day) Relative Deviation Change:** -1.0 (Indicates a recent decrease in relative performance)
*   **Expected Return:** 95.8% (Potential long-term outperformance vs. S&P 500)

**Analysis:**

*   The MRI indicates a relatively low-risk environment.
*   The RSI suggests that the stock is approaching overbought conditions, which could signal a potential pullback.
*   The PPO measures the percentage difference between two moving averages (typically 12-day and 26-day EMAs). It helps identify potential overbought/oversold conditions.

The relative deviation indicates a recent decrease in the stock's outperformance compared to VOO. Given the positive price change compared to the previous close, the recent price jump suggests the market is reacting positively, potentially due to recent news or earnings. The high expected return indicates a strong potential for long-term outperformance.

**4. Recent News & Significant Events**

*   **2025-05-13:** Major business developments, regulatory changes, or market events.
*   **2025-05-12:** Analyst discussions on recent performance and outlook.
*   **2025-05-10:** Stock volatility influenced by news, earnings reports, or executive actions.
*   **2025-05-11:** Market experts highlight both risks and opportunities.

**Analysis:** The recent news indicates that NTRA is experiencing significant activity, including analyst scrutiny, market volatility, and possibly major company events. Investors should monitor these developments closely.

**5. Recent Earnings Analysis:**

| Date       | EPS    | Revenue    |
|------------|--------|------------|
| 2025-05-09 | -0.5   | 0.50 B$    |
| 2024-11-12 | -0.26  | 0.44 B$    |
| 2024-08-09 | -0.3   | 0.41 B$    |
| 2024-05-10 | -0.56  | 0.37 B$    |
| 2025-05-09 | -0.56  | 0.37 B$    |

**Analysis:**

*   NTRA has consistently reported negative EPS (Earnings Per Share), indicating unprofitability.
*   Revenue has been generally increasing.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.50B  | 63.12%       |
| 2024-12-31 | $0.48B  | 62.94%       |
| 2024-09-30 | $0.44B  | 61.79%       |
| 2024-06-30 | $0.41B  | 58.83%       |
| 2024-03-31 | $0.37B  | 56.72%       |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-03-31 | $1.24B  | -5.40%  |
| 2024-12-31 | $1.20B  | -4.50%  |
| 2024-09-30 | $0.88B  | -3.60%  |
| 2024-06-30 | $0.84B  | -4.48%  |
| 2024-03-31 | $0.79B  | -8.51%  |

**Analysis:**

*   Revenue has been increasing steadily over the past several quarters.
*   Profit margins are strong and increasing.
*   Equity has increased significantly over the past year.
*   ROE (Return on Equity) is negative, consistent with the negative EPS, but has shown signs of improvement recently.

**7. Overall Summary**

Natera Inc. (NTRA) is a high-growth, high-risk company in the diagnostics sector. It has shown significant outperformance relative to the S&P 500 historically. Recent data suggests:

*   **Positive:** Strong revenue growth, increasing profit margins, potential for long-term outperformance, and recent positive price momentum.
*   **Negative:** Consistent unprofitability (negative EPS and ROE), high historical volatility (MDD), an RSI approaching overbought levels, and a recent decrease in relative outperformance.

The recent news flow suggests significant activity around the company, and analysts are actively discussing its performance. The company's financials show a strong revenue trend, but profitability remains a concern. Investors should carefully weigh the growth potential against the risks before investing in NTRA.
